'Tell Me Your Story' Allows First Interactions With Patient Population for New Medical Students
First-year medical students participated in the "Tell Me Your Story" field trip as part of their introduction to the clinical skills course on Tuesday, Sept. 6. Another group of medical students will visit the facility on Wednesday, Sept. 7.
This exercise involves visiting and interviewing residents of Maple Knoll Retirement Village to hear about their past experiences with health care.
About 175 students will travel to the Springdale facility to not only gain advice about how to be good physicians, but also to form relationships and friendships with people who may one day be patients. Topics of conversation between students and residents at the facility have a large rangefrom life at Maple Knoll to past physician-patient experiences to favorite pastimes and hobbies.
After students speak with residents of Maple Knoll, they meet in groups with UC faculty and reflect on the stories they have heard and the knowledge gained from the experience.
The program has been in existence for almost eight years, originating from a grant that was awarded to the department of family medicine and being passed on to the division of geriatric medicine.
Gregg Warshaw, MD, director of the division of geriatric medicine, says in this early "patient-encounter its important to show students that the aging population is still vibrant and independent.
"Tell Me Your Story is a particularly exciting educational experience, especially since the new students instructors are healthy, older adults in their 70s, 80s and 90s, he says. "The older adult volunteers look forward to hosting the medical students in their apartments and cottages, and the new medical students have a chance to learn about medical care from experienced consumers.
"Tell Me Your Story" allows first-year medical students to interact with residents at Maple Knoll Village, a retirement community, and hear about their past experiences with physicians.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.